• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

142
20
13
13
11

COUNTRY

6
4
4
4
3

PRICE

6
90
123
516

PUBLISHED

2
16
137
516

PRODUCT TYPE

510
3
2
1

Immune Disorders

(516 Products)

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

Global Neurodegenerative Diseases Market 2015-2019

About neurodegenerative diseases According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech,...

May 2015
FROM

Immunoassay Systems - Global Strategic Business Report

This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following Product Segments, which includes Immunoassay Analyzers and Reagents: Enzyme Immunoassay Systems, Fluorescence...

September 2014
FROM

Autoimmune Diseases Market in the US 2015-2019

About Autoimmune Diseases Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system...

July 2015
FROM

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

November 2014
FROM

Immune Checkpoint Inhibitors Market, 2014 - 2024

Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to...

November 2014
FROM

EpiCast Report: Myasthenia Gravis - Epidemiology Forecast to 2024

EpiCast Report: Myasthenia Gravis - Epidemiology Forecast to 2024 Summary Myasthenia gravis is an autoimmune disease that affects the nerves and muscles and is characterized by muscle weakness and...

June 2015
FROM

Therapy Class Overview : Hepatitis C Virus Infection

Freedom from injecting Interferon (IFN), treating major HCV genotypes WW and betting on vaccines could bring a sea of change in the treatment of HCV infection in the future This year the first IFN-free...

October 2013
FROM
Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape - Product Thumbnail Image

Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Summary "Gene Therapy Immunology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles...

July 2015
FROM

Lung Transplantation - Pipeline Review, H1 2015

Lung Transplantation - Pipeline Review, H1 2015 Summary This, ‘Lung Transplantation - Pipeline Review, H1 2015’, provides an overview of the Lung Transplantation’s therapeutic pipeline. This report...

June 2015
FROM

Pemphigus Vulgaris - Pipeline Review, H1 2015

Pemphigus Vulgaris - Pipeline Review, H1 2015 Summary This, ‘Pemphigus Vulgaris - Pipeline Review, H1 2015’, provides an overview of the Pemphigus Vulgaris’s therapeutic pipeline. This report provides...

June 2015
FROM

Hereditary Angioedema (HAE) - Pipeline Review, H1 2015

Hereditary Angioedema (HAE) - Pipeline Review, H1 2015 Summary This, ‘Hereditary Angioedema (HAE) - Pipeline Review, H1 2015’, provides an overview of the Hereditary Angioedema (HAE)’s therapeutic...

May 2015
FROM

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015 Summary This, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015’, provides an overview of the Plaque Psoriasis (Psoriasis...

May 2015
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015’, provides an overview of the Hematopoietic Stem...

May 2015
FROM

Kidney Transplantation - Pipeline Review, H1 2015

Kidney Transplantation - Pipeline Review, H1 2015 Summary This, ‘Kidney Transplantation - Pipeline Review, H1 2015’, provides an overview of the Kidney Transplantation’s therapeutic pipeline. This...

May 2015
FROM

Hypersensitivity - Pipeline Review, H1 2015

Hypersensitivity - Pipeline Review, H1 2015 Summary This, ‘Hypersensitivity - Pipeline Review, H1 2015’, provides an overview of the Hypersensitivity’s therapeutic pipeline. This report provides...

May 2015
FROM

Cedar Pollen Allergy - Pipeline Review, H1 2015

Cedar Pollen Allergy - Pipeline Review, H1 2015 Summary This, ‘Cedar Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Cedar Pollen Allergy’s therapeutic pipeline. This report...

May 2015
FROM

Sjogren's Syndrome - Pipeline Review, H1 2015

Sjogren's Syndrome - Pipeline Review, H1 2015 Summary This, ‘Sjogren's Syndrome - Pipeline Review, H1 2015’, provides an overview of the Sjogren's Syndrome’s therapeutic pipeline. This report provides...

May 2015
FROM

Wegener's Granulomatosis - Pipeline Review, H1 2015

Wegener's Granulomatosis - Pipeline Review, H1 2015 Summary The‘Wegener's Granulomatosis - Pipeline Review, H1 2015’, provides an overview of the Wegener's Granulomatosis’s therapeutic pipeline. This...

May 2015
FROM

AutoImmune Drug Focus Issue

This first approved generic glatiramer acetate has been a long time coming, but the hesitancy in launching shows that the battle to produce a generic Copaxone is not yet over. FDA approval will nonetheless...

May 2015

Disease & Therapy Review (DTR) Executive Market Summaries

Disease & Therapy Review is meant to be an accurate and efficient executive synopsis of the indications that IPD users look up most frequently Each report includes epidemiology from the IPD (Incidence...

May 2015
Loading Indicator

Our Clients

Merck & Co., Inc. Celgene Corporation GlaxoSmithKline PLC Genentech, Inc. Johnson & Johnson Services, Inc. ViiV Healthcare